Home Data Calendar Blog

ENDP

Tables

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31
Common Stock Value 0.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.01NANANA1.44NANANA
Weighted Average Number Of Diluted Shares Outstanding NA235.16235.12233.88NA233.58233.33238.67234.47230.04233.68233.01226.79226.60226.22224.59224.35224.13223.83223.52223.32223.30223.16223.01222.87222.77222.86222.30225.32209.27185.33176.82153.77153.31163.37128.13115.11120.26117.22113.19
Weighted Average Number Of Shares Outstanding Basic NA235.16235.12233.88NA233.58233.33230.55230.30230.04229.72227.20226.79226.60226.22224.59224.35224.13223.83223.52223.32223.30223.16223.01222.87222.77222.67222.30224.15209.27185.33169.65153.77153.31152.37128.13115.11114.33112.53111.22
Earnings Per Share Basic -1.03-3.07-8.02-0.31-2.41-0.33-0.070.180.52-0.330.050.57-0.96-0.35-0.47-0.08-1.30-0.77-0.27-2.26-1.65-0.43-6.26-0.78-14.98-0.981.54-0.60-0.53-5.02-1.35-0.45-0.35-1.640.14-3.41-6.740.350.310.14
Earnings Per Share Diluted -1.03-3.07-8.02-0.31-2.41-0.33-0.070.170.51-0.330.050.56-0.96-0.35-0.47-0.08-1.30-0.77-0.27-2.26-1.65-0.43-6.26-0.78-14.98-0.981.54-0.60-0.53-5.02-1.35-0.43-0.35-1.640.13-3.41-6.740.330.300.14
Income Loss From Continuing Operations Per Basic Share -0.00-0.00-0.00-0.00-0.00-0.00-0.000.000.00-0.000.000.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.000.00-0.000.00-0.00-0.000.00-0.00-0.000.00-0.00-0.000.000.000.00
Income Loss From Continuing Operations Per Diluted Share -0.00-0.00-0.00-0.00-0.00-0.00-0.000.000.00-0.000.000.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.000.00-0.000.00-0.00-0.000.00-0.00-0.000.00-0.00-0.000.000.000.00

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31
Revenue From Contract With Customer Excluding Assessed Tax 555.81541.69569.11652.26789.43772.03713.83717.92760.22634.86687.59820.40764.80729.43699.73720.41786.39745.47714.70700.53768.64786.89875.731037.601241.51884.34920.89963.541073.70745.73735.17714.13799.96763.94718.68594.61584.95661.32712.15658.49
Revenues 555.81541.69569.11652.26789.43772.03713.83717.92760.22634.86687.59820.40764.80729.43699.73720.41786.39745.47714.70700.53768.64786.89875.731037.601241.51884.34920.89963.541073.70745.73735.17714.13799.96763.94718.68594.61584.95661.32712.15658.49
Cost Of Revenue 294.27261.23263.79273.21311.22286.07318.48305.29369.54348.08336.10388.80400.06389.17388.21391.91433.21412.96381.90403.60505.64514.52539.40668.96756.58557.47632.22688.71810.07442.46438.86384.27423.66379.20345.74251.96253.89257.84273.41254.38
Cost Of Goods And Services Sold 294.27261.23263.79273.21311.22286.07318.48305.29369.54348.08336.10388.80400.06389.17388.21391.91433.21412.96381.90403.60505.64514.52539.40668.96756.58557.47632.22688.71810.07442.46438.86384.27374.21341.19303.45212.65212.65221.82234.55217.27
Research And Development Expense Excluding Acquired In Process Cost 30.2331.8929.7936.1338.4225.6229.6729.74NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Selling General And Administrative Expense 176.96192.22180.83227.16250.10246.86177.62187.17176.22182.26173.26166.77160.67168.33152.30151.12167.42163.79148.16166.67161.20135.88155.56177.24212.57186.74193.07178.35212.01163.22154.49211.58192.28205.26171.61226.70186.44191.36244.30227.23
Interest Expense 0.2974.75139.78134.95143.50142.96141.55134.34135.25135.65129.16132.88134.35136.90134.81132.68NANANANANANANANANANANANANANANANANANANANANANANANA
Interest Expense Debt 231.0077.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Income Loss From Continuing Operations -245.16-718.27-1880.88-65.30-556.67-49.29-10.1847.06141.25-68.9717.61157.58-208.49-41.43-98.05-12.61-265.48-146.07-52.48-497.74-271.58-99.69-696.02-165.42-3333.32-191.50389.79-88.76443.71-803.66-90.79150.4919.48-252.0824.33-438.80-668.0869.1741.7521.65
Income Tax Expense Benefit 5.5010.687.15-1.819.111.5511.100.72-149.474.177.64-136.33-16.0517.363.4710.90-1.793.006.2415.49-152.79-28.11-57.48-11.90-72.2846.19-555.28-118.72-796.94-160.94-12.72-166.87-63.25-138.7615.59-215.42-106.9844.6629.019.25
Net Income Loss -243.53-722.17-1885.43-71.97-562.06-77.21-15.5041.52119.34-75.8910.56129.93-218.64-79.42-106.00-18.57-291.91-173.21-60.87-505.49-368.42-96.67-1396.52-173.83-3337.86-218.92343.58-133.87-118.46-1050.44-250.42-75.72-53.48-252.0821.16-436.91-775.9140.2235.0015.35
Comprehensive Income Net Of Tax -240.94-732.82-1889.76-70.08-561.39-80.50-13.2643.22126.74-73.1316.18115.49-215.11-81.93-101.61-13.84-304.28-168.47-66.84-511.29-289.88-57.22-1385.69-159.04-3359.14-224.97321.84-54.02-193.98-1110.05-242.27-204.95-133.49-344.3669.53-432.18-774.8943.1635.2912.98

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31
Assets 5757.946006.466362.268447.218767.429246.559206.269234.179264.649165.249165.139305.889389.539834.8710074.299803.3210132.3910521.6610858.0310933.7511635.5811895.4712278.0913218.6514275.1117683.5017935.5318636.8019350.3421480.8616131.9114145.6810909.6210589.559961.919527.976571.86NANANA
Liabilities And Stockholders Equity 5757.946006.466362.268447.218767.429246.559206.269234.179264.649165.249165.139305.889389.539834.8710074.299803.3210132.3910521.6610858.0310933.7511635.5811895.4712278.0913218.6514275.1117683.5017935.5318636.8019350.3421480.8616131.9114145.6810909.6210589.559961.919527.976571.86NANANA
Stockholders Equity -4162.17-3925.04-3198.07-1311.00-1243.99-690.32-617.04-598.97-647.94-782.48-714.87-737.82-866.54-661.48-590.47-494.45-498.28-219.46-62.08-7.09484.88NANANA2701.596050.866261.545924.155968.036396.066151.874139.602374.762490.722807.492967.34526.02NANANA

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31
Assets Current 2076.772054.162199.902492.792714.592748.952569.332495.232413.262802.822686.142735.342586.222649.142755.052272.132343.152275.602308.902208.452271.082196.482275.012332.722589.462247.442650.423079.903475.154799.487536.955327.873307.472981.503164.782790.192854.51NANANA
Cash And Cash Equivalents At Carrying Value 1018.881053.891191.571413.151507.201568.661545.171427.781213.441679.741780.091531.541454.531526.251446.95981.741149.111118.881098.79980.41986.61738.39616.53617.59517.25561.58667.82221.97272.35836.112529.74377.46408.75708.531427.241041.28526.60575.33493.35327.01
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1249.241284.381390.071594.921631.311700.271673.731564.841385.001860.791979.221750.601720.391771.101776.891336.641476.841430.911479.361320.231311.011103.49985.29901.69805.18NANANA863.08NANANA936.63NANANANANANANA
Accounts Receivable Net Current 493.99423.46491.49473.30592.02533.83458.14473.15511.26473.37271.89536.90467.95420.19442.08487.97470.57467.16451.24460.02517.44531.49580.12689.60992.15669.82875.06867.83995.081837.561318.291235.381234.731039.84875.93790.51725.83NANANA
Inventory Net 274.50288.91287.76283.83283.55297.30338.46362.18352.26354.90330.54324.96327.87338.51335.89331.39322.18332.79343.32376.65391.44443.27489.75549.14555.67624.30626.32670.45744.66946.65625.77611.40472.21503.61427.20464.10374.44NANANA
Prepaid Expense And Other Assets Current 136.92141.1297.11131.39200.48167.3489.2286.06100.9066.2155.8146.5440.84105.35183.15104.9056.1450.7045.3046.7343.1032.7233.3339.6777.5275.5745.9947.7353.53104.0851.5654.6043.6036.9444.0787.8239.40NANANA

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31
Amortization Of Intangible Assets 75.4784.0487.5790.2391.8191.9094.1095.13101.74104.10104.50117.24125.91131.90140.40145.60150.68161.30153.20157.17158.27161.40191.00263.13240.44211.50212.80211.67227.54121.50116.9995.2786.3070.8168.2755.1942.2044.9951.0947.25
Goodwill 1352.011352.011449.013197.013197.013560.013560.013560.013560.013560.013560.013560.013595.183615.323615.703679.803764.644056.674055.194056.854450.084450.804447.314650.334729.407411.627417.247424.787299.356667.173044.313025.073762.553804.963533.153522.651372.83NANANA
Intangible Assets Net Excluding Goodwill 1732.931992.932133.952253.272362.822454.362548.662643.992740.812178.862281.172382.372571.272938.223075.653235.593457.313624.223923.874102.704317.684602.384836.095487.865859.306975.587096.667354.397812.659088.204914.395070.073194.373133.962671.912662.681872.93NANANA
Other Assets Noncurrent 129.84144.56142.3062.5860.3148.6448.4446.5553.2394.7498.4186.3578.1077.0077.2962.6366.9967.9368.5351.2059.7367.7578.5667.53417.28371.1686.1992.2579.60265.41215.30309.54209.84251.90200.53168.6096.53NANANA

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31
Liabilities Current 689.63543.051181.671376.141629.961554.271409.211395.491253.821291.001222.411346.991460.291667.731835.821751.291950.102021.472153.072087.602220.912042.122226.952059.162634.742662.302938.843206.973474.313960.263487.443442.023099.242264.762176.242028.061696.67NANANA
Long Term Debt Current NANA26.1226.12200.34223.14223.14200.3434.1534.1534.1534.1534.1534.1534.1535.9434.1534.1534.2034.2034.2034.2034.1525.61131.12124.25117.45335.58328.7089.8368.42160.61155.94153.23185.63402.25414.93NANANA
Accounts Payable And Accrued Liabilities Current 687.18538.73749.87808.28836.90921.02825.00855.40835.94868.40756.36854.96899.95937.18931.21840.831009.201019.001027.36953.201096.831097.181233.341219.281454.08NANANA1510.12NANANANANANANANANANANA
Other Accrued Liabilities Current 123.0983.5295.12108.17114.56138.17132.43121.74108.29117.49117.99150.41146.44171.81171.22176.60149.78212.91187.16174.37159.68213.52203.76196.80189.84NANANA246.55NANANA273.04NANANA193.94NANANA
Accrued Income Taxes Current 1.543.604.032.180.74NA0.000.04NA2.241.644.142.4210.883.521.141.661.681.781.382.098.055.2618.439.275.767.158.678.5560.1411.3642.820.000.000.000.003.09NANANA
Contract With Customer Liability Current 0.600.600.600.600.600.601.001.401.402.901.401.401.402.103.402.801.701.701.701.80NANANANANANANANANANANANANANANANANANANANA

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31
Long Term Debt 7834.727979.188065.308067.118249.328274.028275.968277.968314.738320.508336.758389.078394.058399.068404.128111.288258.428262.768267.218271.698276.248280.818285.448250.178272.508426.568454.268706.888727.638979.335429.655547.164358.294372.544415.533897.893738.77NANANA
Long Term Debt Noncurrent NANA8039.188040.998048.988050.878052.818077.628280.588286.358302.598354.928359.908364.918369.978075.348224.278228.618233.008237.498242.038246.608251.298224.568141.388170.628199.898229.198251.668889.495361.235386.554202.364219.314229.903495.653323.84NANANA
Deferred Income Tax Liabilities Net 13.8211.6314.9015.9621.6322.5222.9324.3526.0726.9328.1727.0231.7032.1033.4033.5834.4943.6342.9142.5843.1380.4179.81155.27192.30NANANA871.04NANANANANANANANANANANA
Other Liabilities Noncurrent 42.7527.20290.51288.43277.10274.06305.47299.94313.98303.22284.15269.70355.88371.52373.39383.31421.82411.96420.39431.11434.18433.56485.19591.60605.10621.45237.71239.29236.25371.64411.40423.14212.741086.61481.92715.15654.49NANANA
Operating Lease Liability Noncurrent 5.134.3629.0731.6933.7335.1532.8735.7438.1340.2242.6745.0648.3050.9752.1954.260.00NANANANANANANANANANANANANANANANANANANANANANANA

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31
Stockholders Equity -4162.17-3925.04-3198.07-1311.00-1243.99-690.32-617.04-598.97-647.94-782.48-714.87-737.82-866.54-661.48-590.47-494.45-498.28-219.46-62.08-7.09484.88NANANA2701.596050.866261.545924.155968.036396.066151.874139.602374.762490.722807.492967.34526.02NANANA
Common Stock Value 0.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.01NANANA1.44NANANA
Additional Paid In Capital 8969.328965.518959.668956.978953.918946.188938.968943.768938.018930.218924.698917.938904.698894.658883.728878.138855.818830.358819.268807.418791.178781.408768.318761.578743.248733.368719.078703.528693.398676.347322.105067.563093.873076.343048.753278.121166.38NANANA
Retained Earnings Accumulated Deficit -12904.62-12661.08-11938.92-10053.49-9981.51-9419.45-9342.25-9326.75-9368.27-9487.61-9411.73-9422.28-9552.21-9333.57-9254.16-9148.15-9124.93-8833.02-8659.82-8598.95-8096.54-7728.12-7631.45-6234.93-5688.28-2350.43-2131.51-2475.08-2341.22-1971.66-921.22-670.80-595.09-541.60-289.52-310.68126.23NANANA
Accumulated Other Comprehensive Income Loss Net Of Tax -226.94-229.53-218.88-214.55-216.44-217.12-213.82-216.06-217.75-225.15-227.90-233.53-219.09-222.62-220.10-224.50-229.23-216.85-221.59-215.62-209.82-288.36-327.81-338.65-353.43-332.14-326.10-304.36-384.20-308.68-249.08-257.22-124.09-44.0948.19-0.18-4.92NANANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value NA5.862.724.93NA7.804.449.99NA6.589.2217.64NA11.5812.6024.73NA13.7412.1017.89NA13.257.5119.49NA14.9814.6214.97NA23.7810.9213.84NA8.77NANANANANANA

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31
Net Cash Provided By Used In Operating Activities 109.5891.71-133.42201.32-49.8662.10154.98243.84107.95-77.44304.3362.56-21.1932.64177.19-90.5870.28-22.14170.2948.85129.9283.08173.22167.7681.06-111.32604.52-49.83239.46-99.9512.32-89.81105.57284.83194.31-246.9426.05155.44175.78-58.75
Net Cash Provided By Used In Investing Activities 1.40-22.80-62.90-48.8410.80-25.30-28.00-17.05-574.64-18.82-15.45-15.96-14.87-23.01-5.94-16.38-4.22-4.696.61-15.60174.3853.98-116.66-7.12-53.0141.86105.9431.07-284.27-5054.1524.14-930.48-393.01-967.18-53.46641.80-756.65-73.64-16.06-37.29
Net Cash Provided By Used In Financing Activities -146.55-170.37-7.75-189.20-29.95-9.79-18.40-47.35-10.21-22.63-61.25-14.48-14.96-15.37268.70-33.77-18.76-22.02-17.38-23.41-31.64-35.77-46.39-53.19-59.47-36.82-263.10-34.59-515.083454.142119.55996.86-9.85-30.10240.41102.40680.006.474.01-110.95

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31
Net Cash Provided By Used In Operating Activities 109.5891.71-133.42201.32-49.8662.10154.98243.84107.95-77.44304.3362.56-21.1932.64177.19-90.5870.28-22.14170.2948.85129.9283.08173.22167.7681.06-111.32604.52-49.83239.46-99.9512.32-89.81105.57284.83194.31-246.9426.05155.44175.78-58.75
Net Income Loss -243.53-722.17-1885.43-71.97-562.06-77.21-15.5041.52119.34-75.8910.56129.93-218.64-79.42-106.00-18.57-291.91-173.21-60.87-505.49-368.42-96.67-1396.52-173.83-3337.86-218.92343.58-133.87-118.46-1050.44-250.42-75.72-53.48-252.0821.16-436.91-775.9140.2235.0015.35
Increase Decrease In Accounts Receivable 48.73-61.1325.32-118.8458.4575.88-15.10-37.1837.16201.23-265.4372.8339.47-24.07-48.9514.3914.5417.11-9.03-39.71-14.53-62.04-99.07-310.72349.40-208.368.50-142.1554.0296.2984.7439.94197.55121.6366.12-43.8989.94-32.700.9621.99
Increase Decrease In Inventories -26.745.7313.3412.03-19.25-9.32-24.213.80-25.0324.348.390.32-5.623.5917.2411.93-14.77-8.85-38.86-4.79-158.15-36.5619.0228.4984.587.62-11.35-18.48-60.959.4012.2610.1741.81-48.26-42.546.64-30.40-13.4946.0327.15
Share Based Compensation 3.815.862.724.937.817.804.449.997.916.589.2217.6410.2311.5812.6024.7310.3513.7012.1017.899.9013.207.5019.5015.2014.9814.6214.9712.6523.7810.9213.849.528.776.787.597.748.517.4215.33
Amortization Of Financing Costs NA89.20NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31
Net Cash Provided By Used In Investing Activities 1.40-22.80-62.90-48.8410.80-25.30-28.00-17.05-574.64-18.82-15.45-15.96-14.87-23.01-5.94-16.38-4.22-4.696.61-15.60174.3853.98-116.66-7.12-53.0141.86105.9431.07-284.27-5054.1524.14-930.48-393.01-967.18-53.46641.80-756.65-73.64-16.06-37.29
Payments To Acquire Property Plant And Equipment 21.8630.3124.5323.0216.4320.1524.6116.7317.2816.3916.6719.6416.0424.188.2515.3926.8514.5817.0924.8731.5534.3732.5327.2050.7734.3827.7126.0030.8312.3221.4317.1923.1216.9019.5620.8442.1316.8813.5123.96

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31
Net Cash Provided By Used In Financing Activities -146.55-170.37-7.75-189.20-29.95-9.79-18.40-47.35-10.21-22.63-61.25-14.48-14.96-15.37268.70-33.77-18.76-22.02-17.38-23.41-31.64-35.77-46.39-53.19-59.47-36.82-263.10-34.59-515.083454.142119.55996.86-9.85-30.10240.41102.40680.006.474.01-110.95

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31
Revenues 555.81541.69569.11652.26789.43772.03713.83717.92760.22634.86687.59820.40764.80729.43699.73720.41786.39745.47714.70700.53768.64786.89875.731037.601241.51884.34920.89963.541073.70745.73735.17714.13799.96763.94718.68594.61584.95661.32712.15658.49
Revenue From Contract With Customer Excluding Assessed Tax 555.81541.69569.11652.26789.43772.03713.83717.92760.22634.86687.59820.40764.80729.43699.73720.41786.39745.47714.70700.53768.64786.89875.731037.601241.51884.34920.89963.541073.70745.73735.17714.13799.96763.94718.68594.61584.95661.32712.15658.49
Reorganization Chapter11 Debtor In Possession 556.20541.89NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Adrenalin, Sterile Injectables 28.7924.9226.7733.8236.4928.7229.9829.4431.7430.6633.1656.5145.8340.3145.84NANANANANANANANANANANANANANANANANANANANANANANANANA
Established Products, Branded Pharmaceuticals 61.3857.1755.0955.8067.1569.0660.9563.3070.5983.5660.7869.7876.9385.3184.92NANANANANANANANANANANANANANANANANANANANANANANANANA
Lidoderm, Branded Pharmaceuticals 10.409.4310.028.8811.3211.699.4411.198.3618.070.628.1914.4113.249.05NANANANANANANANANANANANANANANANANANANANANANANANANA
Other Established Products, Branded Pharmaceuticals 24.5222.6918.8120.7530.7430.4625.3526.4934.9137.9932.5833.8834.7043.5239.33NANANANANANANANANANANANANANANANANANANANANANANANANA
Other Specialty Products, Branded Pharmaceuticals 19.9911.0318.2520.7412.0326.3428.0420.0323.8723.7219.5725.5026.8428.4725.52NANANANANANANANANANANANANANANANANANANANANANANANANA
Other Sterile Injectables, Sterile Injectables 50.4760.0860.7750.3157.6359.2367.5055.36-14.8365.3271.8476.97NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
PERCOCET, Branded Pharmaceuticals 26.4625.0526.2626.1825.0926.9126.1625.6227.3227.5127.5827.7027.8128.5628.88NANANANANANANANANANANANANANANANANANANANANANANANANA
SUPPRELINLA, Branded Pharmaceuticals 28.1631.2824.7428.8328.7130.0727.5728.0324.8428.2315.3919.7220.2520.7723.71NANANANANANANANANANANANANANANANANANANANANANANANANA
Specialty Products, Branded Pharmaceuticals 162.45146.33163.86149.06160.81161.92167.09143.33153.92140.1268.74134.30148.62132.00124.09NANANANANANANANANANANANANANANANANANANANANANANANANA
Vasostrict, Sterile Injectables 28.4833.7035.63155.89224.97255.70197.12223.95213.12155.41214.21202.90146.88129.69116.03NANANANANANANANANANANANANANANANANANANANANANANANANA
Xiaflex, Branded Pharmaceuticals 114.30104.01120.8899.48120.08105.51111.4995.27105.2188.1733.7889.07101.5282.7674.86NANANANANANANANANANANANANANANANANANANANANANANANANA
Branded Pharmaceuticals 223.83203.50218.95204.86227.97230.98228.04206.63224.50223.68129.52204.07225.55217.31209.01NANANANANA228.38233.80245.19250.16289.30279.84288.34308.81379.41304.78315.91284.51245.79240.93248.55234.16254.64366.14415.65357.59
Generic Pharmaceuticals 204.70201.44203.38185.94218.13174.31167.27180.87180.44135.51215.88251.28225.56218.01217.78218.53263.77257.97241.24249.24499.05496.65563.31721.98882.17533.69565.36583.39609.20367.93338.33356.96337.35319.40272.21211.85197.94183.94170.53178.25
International Pharmaceuticals 19.5418.0623.6121.4324.2323.0923.9221.6723.4324.2822.9728.6628.5230.4728.6528.3134.0430.2542.9835.2041.2156.4367.2365.4670.0470.8067.1971.3485.0973.0280.9372.6679.7393.7972.0924.820.000.000.000.00
Sterile Injectables 107.74118.69123.17240.03319.10343.65294.60308.75331.85251.39319.21336.39285.17263.63244.28NANANANANANANANANANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Net Income Loss
Expenses
Other Nonoperating Income Expense
Balance Sheet
Stockholders Equity
Assets
Operating Lease Right Of Use Asset
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Deferred Income Tax Assets Net
Liabilities
Operating Lease Liability
Current Liabilities
Contract With Customer Liability Current
Noncurrent Liabilities
Operating Lease Liability Noncurrent
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
Shares
Weighted Average Number Of Diluted Shares Outstanding
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Other Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Undiscounted Excess Amount
InventoryNet
Inventory Work In Process Net Of Reserves

Line plots across dimensions of each concept


us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementBusinessSegments
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:StatementBusinessSegments
(None, 'endp:BrandedPharmaceuticals')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:StatementBusinessSegments
(None, 'endp:SterileInjectables')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Statement Business Segments
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:AmortizationOfIntangibleAssets
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
(None,)
Amortization Of Intangible Assetsus-gaap: Finite Lived Intangible Assets By Major Class
us-gaap:Goodwill
us-gaap:StatementBusinessSegments
(None,)
Goodwillus-gaap: Statement Business Segments
us-gaap:LongTermDebt
us-gaap:DebtInstrument
(None,)
Long Term Debtus-gaap: Debt Instrument
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementBusinessSegments
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:StatementBusinessSegments
(None, 'endp:BrandedPharmaceuticals')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:StatementBusinessSegments
(None, 'endp:SterileInjectables')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Statement Business Segments